PROVIDER PROFILE · NPI 1730281957

Richard SpaideMD

OphthalmologyNew York, NYI
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
3,159
Unique beneficiaries
—
Total services
59,739
Distinct HCPCS
13
Medicare payment
$2.1M
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 1,438 Ophthalmology providers in NY — top quintile (cohort median 1,869).
PRESCRIBING · PART D · 2024
Total Rx claims
218
Beneficiaries
—
Total drug cost
$12K
Distinct drugs
10
Brand share
21.6%
Top prescribed drugs
QUALITY · MIPS · 2024
Final MIPS score
100.0
Quality
100.0
Cost
0.0
Improvement activities
40.0
Promoting interop.
0.0
Payment adjustment
1.05%
Group
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2025
Total received
$204K
Payment records
28
By payment type
Royalty or License$150K
Consulting Fee$38K
Travel and Lodging$15K
Food and Beverage$981
Top paying entities
Royalty or License$150K
Consulting Fee$38K
Travel and Lodging$15K
Food and Beverage$981
FACILITY AFFILIATIONS

Hospital & Facility Affiliations (1)

Hospital
REFERRAL NETWORK

Where Richard Spaide's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 7 inbound referrers · 0 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
Laboratory Corporation Of America Holdings
Clinical Laboratory · Raritan, NJ
2032
LENOX HILL HOSPITAL1965
NEW YORK EYE & EAR INFIRMARY1928
Bioreference Health, Llc
Clinical Laboratory · Elmwood Park, NJ
1735
Sunrise Medical Laboratories, Inc.
Clinical Laboratory · Hicksville, NY
1531
MOUNT SINAI HOSPITAL1429
ENZO CLINICAL LABS, INC.1233
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.